Evidence map›Paper›PMID 31624929›Full record

ReviewCurrent psychiatry reports2019

Ovarian Hormones as a Source of Fluctuating Biological Vulnerability in Borderline Personality Disorder.

Jessica R Peters, Tory A Eisenlohr-Moul

Abstract readReview
In one paragraph

Review in Current psychiatry reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. The impact of ovulation-suppressing contraceptives on behavioral and functional difficulties in borderline personality disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Association between Dietary Habits and Severity of Symptoms in Premenstrual Syndrome.International journal of environmental research and public health · 2023
    Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jessica R PetersDepartment of Psychiatry and Human Behavior, Alpert Medical School at Brown University, Box G-BH, Providence, RI, 02912, USA. jessica_peters@brown.edu.ORCID 0000-0003-3150-3973
Tory A Eisenlohr-MoulDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, 60612, USA.ORCID 0000-0002-9231-3105

Funding

Anger Rumination in the Development of PsychopathologyK23MH112889 · NIMH · BROWN UNIVERSITY · PI PETERS, JESSICA RACHAEL · 2018 to 2022
$966k
Ovarian Hormone Withdrawal and Suicide Risk: An Experimental ApproachR00MH109667 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI EISENLOHR-MOUL, TORY ANNE · 2018 to 2020
$747k
NIMH NIH HHS K23 MH112889NIMH NIH HHS R00 MH109667
6 · The paper itself

Abstract

purpose of reviewTo examine the potential role of ovarian hormones in biological vulnerability to borderline personality disorder (BPD). The review focuses primarily on research examining the menstrual cycle as a source of short-term lability of BPD symptom expression, while discussing the currently understudied possibility of ovarian hormone influence in the developmental course of BPD.

findingsSeveral patterns of menstrual cycle effects on BPD symptoms and relevant features in non-clinical samples have been observed in empirical studies. Most symptoms demonstrated patterns consistent with perimenstrual exacerbation; however, timing varied between high and low arousal symptoms, potentially reflecting differing mechanisms. Symptoms are typically lowest around ovulation, with an exception for proactive aggression and some forms of impulsive behaviors. Preliminary evidence suggests ovarian hormones may exert strong effects on BPD symptom expression, and further research is warranted examining mechanisms and developing interventions. Recommendations for researchers and clinicians working with BPD are provided.

Indexed as

AggressionBorderline Personality DisorderFemaleGonadal HormonesHumansImpulsive BehaviorMenstrual CycleOvaryGonadal HormonesBorderline personality disorderEstradiolMenstrual cyclePremenstrual dysphoric disorderPremenstrual exacerbationProgesterone

Identifiers

PMID31624929
PMCPMC7047501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.